Skip to main content

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 '22

By: Newsfile

Dallas, Texas--(Newsfile Corp. - April 10, 2023) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): The full report can be accessed by clicking on the following link: https://stonegateinc.com/reports/BPTH_Q422.pdf

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • Owning the Breakthrough Technology
  • Ongoing Clinical Trials
  • First Patients Recently Dosed

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7294/161882_figure1_550.jpg

Click image above to view full announcement.


About Stonegate Capital Partners
Stonegate Capital Partners is a Dallas-based corporate advisory firm dedicated to serving the specialized needs of small-cap public companies. Since our inception, our mission has been to find innovative, undervalued public companies for our network of leading institutional investors who seek high-quality investment opportunities.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/161882

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.14
+3.71 (1.62%)
AAPL  272.36
+1.39 (0.51%)
AMD  214.90
-0.05 (-0.02%)
BAC  55.97
+0.09 (0.16%)
GOOG  315.68
+4.35 (1.40%)
META  664.94
+3.44 (0.52%)
MSFT  486.85
+1.93 (0.40%)
NVDA  189.21
+5.52 (3.01%)
ORCL  195.34
-3.04 (-1.53%)
TSLA  485.56
-3.17 (-0.65%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.